By Sabela Ojea FibroGen said Tuesday that it named Thane Wettig as its interim chief executive to succeed Enrique Conterno in the role. The biotechnology.
FibroGen, Inc (NASDAQ:FGEN) Receives Consensus Recommendation of Reduce from Analysts kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Raymond James downgraded shares of FibroGen (NASDAQ:FGEN – Free Report) from an outperform rating to a market perform rating in a research report released on Monday, The Fly reports. FGEN has been the subject of several other reports. Stifel Nicolaus upgraded shares of FibroGen from a hold rating to a buy rating and upped their […]
FibroGen, Inc. (NASDAQ:FGEN – Free Report) insider Thane Wettig sold 791 shares of the firm’s stock in a transaction that occurred on Friday, June 23rd. The stock was sold at an average price of $16.53, for a total transaction of $13,075.23. Following the transaction, the insider now directly owns 108,261 shares of the company’s stock, […]
FibroGen (NASDAQ:FGEN – Get Rating) was downgraded by stock analysts at Bank of America from a “buy” rating to a “neutral” rating in a research note issued on Monday, The Fly reports. Other analysts have also issued reports about the company. William Blair lowered FibroGen from an “outperform” rating to a “market perform” rating in […]